Monocyte TREM-1 membrane expression in non-infectious inflammation

Jean-Marc Cavaillon1

  • 1Unit Cytokines & Inflammation, Institut Pasteur, 75015 Paris, France. jean-marc.cavaillon@pasteur.fr

Insights

Both sterile inflammation and severe infections share similar inflammatory events. Increased expression of triggering receptor expressed on myeloid cells 1 (TREM1) on immune cells is a key marker in both conditions.

Area of Science:

  • Immunology
  • Cell Biology
  • Pathology

Background:

  • Sterile inflammation and severe infections exhibit overlapping pathophysiological events.
  • Molecular patterns, such as damage-associated molecular patterns (DAMPs) and pathogen-associated molecular patterns (PAMPs), initiate inflammatory responses.
  • These patterns trigger the release of inflammatory mediators and alter cell surface receptor expression.

Purpose of the Study:

  • To elucidate the shared molecular mechanisms underlying sterile and infectious inflammation.
  • To identify common cellular markers indicative of both inflammatory states.

Main Methods:

  • Analysis of inflammatory mediator release.
  • Assessment of cell surface receptor expression, specifically focusing on myeloid cells.
  • Comparative study of immune responses in sterile versus infectious inflammatory conditions.

Main Results:

  • Both sterile and infectious inflammation involve similar inflammatory mediator release.
  • A significant increase in the expression of triggering receptor expressed on myeloid cells 1 (TREM1) was observed on monocytes and neutrophils in both conditions.
  • TREM1 expression serves as a common hallmark for both infectious and non-infectious inflammatory processes.

Conclusions:

  • Infectious and sterile inflammation share common molecular triggers and cellular responses.
  • Increased TREM1 expression on myeloid cells is a conserved marker for diverse inflammatory conditions.
  • Targeting TREM1 may offer therapeutic potential for a broad range of inflammatory diseases.